| 1. |
Titulaer M J, Mccracken L, Gabilondo I, <italic>et al</italic>. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurology, 2013, 12(2): 157-165.
|
| 2. |
Lancaster E, Lai M, Peng X, <italic>et al</italic>. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurology, 2010, 9(1): 67-76.
|
| 3. |
Hoftberger R, Titulaer M J, Sabater L, <italic>et al</italic>. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology, 2013, 81(17): 1500-1506.
|
| 4. |
Scheffer I E, Berkovic S, Capovilla G, <italic>et al</italic>. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 2017, 58(4): 512-521.
|
| 5. |
Guan HZ, Ren HT, Yang XZ, <italic>et al</italic>. Limbic encephalitis associated with anti-γ-aminobutyric acid B receptor antibodies: a case Series from China. Chinese Medical Journal, 2015, 128(22): 3023-3028.
|
| 6. |
中華醫學會神經病學分會. 中國自身免疫性腦炎診治專家共識. 中華神經科雜志, 2017, 50(2): 91.
|
| 7. |
Graus F, Titulaer M J, Balu R, <italic>et al</italic>. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology, 2016, 15(4): 391-404.
|
| 8. |
關鴻志, 崔麗英. 抗體相關的中樞神經系統自身免疫性疾病: 探索與挑戰. 中華神經科雜志, 2019, 52(2): 81.
|